Prolintane


Concise Prescribing Info
Contraindications
CV disease; moderate to severe hypertension; hyperthyroidism; glaucoma; hyperexcitablity or agitated state; history of drug/alcohol abuse; advanced arteriosclerosis; pregnancy; lactation.
Special Precautions
Mild hypertension; impaired kidney function or unstable personality. Monitor child weight and height. Psychoses may be exacerbated. Dependence. Epilepsy. Gradual withdrawal is recommended after prolonged treatment.
Adverse Reactions
Insomnia, night terrors, nervousness, restlessness, irritability, euphoria; fatigue, depression; dry mouth, anorexia, abdominal cramps, headache, dizziness, tremor, sweating, tachycardia, palpitations, hypo- or hypertension, impotence and altered libido. Psychosis, muscle damage and renal complications.
Overdosage
May cause hallucination, psychosis and death.
Drug Interactions
Increased risk of arrhythmias when used with volatile liquid anaesthetics or TCAs.
Potentially Fatal: Concurrent use with MAOIs or within 14 days of discontinuing MAOI treatment may precipitate hypertensive crisis.
Action
Description: Prolintane is a mild central stimulant. It acts indirectly as a sympathomimetic.
Disclaimer: This information is independently developed by MIMS based on Prolintane from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2020 MIMS. All rights reserved. Powered by MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in